77 B.3.1 Cancer Colorectal métastatique (CCRm), p.78 ,
AVASTIN associe le bévacizumab avec une chimiothérapie de 2 médicaments anticancéreux (le 5-FU et l'irinotécan commercialisé sous le nom CAMPTO) ,
Ce protocole peut être répété toutes les 2 semaines jusqu'à atteindre le nombre de cycles voulus ,
Vascular Endothelial Growth Factor Stimulates Tyrosine Phosphorylation and Recruitment to New Focal Adhesions of Focal Adhesion Kinase and Paxillin in Endothelial Cells, Journal of Biological Chemistry, vol.269, issue.24, pp.15442-15451, 1997. ,
DOI : 10.1083/jcb.135.5.1383
Intravitreal bevacizumab (Avastin) for occult choroidal neovascularization in age-related macular degeneration, Graefe's Archive for Clinical and Experimental Ophthalmology, vol.25, issue.7, pp.941-949, 2007. ,
DOI : 10.1001/archopht.117.10.1329
Thalidomide is an inhibitor of angiogenesis., Proceedings of the National Academy of Sciences, vol.91, issue.9, p.4082, 1994. ,
DOI : 10.1073/pnas.91.9.4082
Aflibercept (Zaltrap®) approved in Metastatic Colorectal Cancer. Bull Cancer, pp.1023-1025, 2013. ,
Regorafenib approved in Metastatic Colorectal cancer. Bull Cancer, pp.1027-1029, 2013. ,
Regorafenib for Gastrointestinal Malignancies, BioDrugs, vol.13, issue.Suppl. 2, p.2013 ,
DOI : 10.1158/1078-0432.CCR-07-0484
SIX-MONTH STABILITY OF BEVACIZUMAB (AVASTIN) BINDING TO VASCULAR ENDOTHELIAL GROWTH FACTOR AFTER WITHDRAWAL INTO A SYRINGE AND REFRIGERATION OR FREEZING, Retina, vol.26, issue.5, pp.519-541, 2006. ,
DOI : 10.1097/01.iae.0000225354.92444.7a
The BOLERO-2 trial: the addition of everolimus to exemestane in the treatment of postmenopausal hormone receptor-positive advanced breast cancer, Future Oncology, vol.9, issue.6, pp.651-658 ,
DOI : 10.1093/jnci/djk020
The hypoxia-inducible-factor hydroxylases bring fresh air into hypoxia signalling, EMBO reports, vol.56, issue.1, pp.41-46, 2006. ,
DOI : 10.1074/jbc.M211058200
URL : https://hal.archives-ouvertes.fr/hal-00321549
Angiogenèse et cancer. Bull Cancer, Sept, vol.84, issue.9, pp.885-890, 1997. ,
Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy, Biochemical and Biophysical Research Communications, vol.333, issue.2, pp.328-335, 2005. ,
DOI : 10.1016/j.bbrc.2005.05.132
VEGF and the quest for tumour angiogenesis factors, Nature Reviews Cancer, vol.120, issue.10, pp.795-803, 2002. ,
DOI : 10.1001/archopht.120.3.338
Mechanisms of adaptive angiogenesis to tissue hypoxia, Angiogenesis, vol.336, issue.1, pp.121-161, 2008. ,
DOI : 10.4161/cc.6.5.3922
Everolimus in the treatment of subependymal giant cell astrocytomas, angiomyolipomas, and pulmonary and skin lesions associated with tuberous sclerosis complex, Biologics: Targets and Therapy, vol.7, pp.211-221, 2013. ,
DOI : 10.2147/BTT.S25095
mTor Signaling in Skeletal Muscle During Sepsis and Inflammation: Where Does It All Go Wrong?, Physiology, vol.262, issue.2, pp.83-96, 2011. ,
DOI : 10.1016/j.freeradbiomed.2010.07.006
URL : http://physiologyonline.physiology.org/content/nips/26/2/83.full.pdf
The International Intravitreal Bevacizumab Safety Survey: using the internet to assess drug safety worldwide, British Journal of Ophthalmology, vol.90, issue.11, pp.1344-1353, 2006. ,
DOI : 10.1136/bjo.2006.099598
Loss of an EGFRamplified chromosome 7 as a novel mechanism of acquired resistance to EGFR-TKIs in EGFR-mutated NSCLC cells. Lung Cancer, 2013. ,
Expression, Journal of Biological Chemistry, vol.92, issue.4, pp.2737-2746, 2004. ,
DOI : 10.1101/gad.1069003
La situation du cancer en France en, 2011. ,
Situation de la chimiothérapie des cancers -Rappor t 2012. Collection États des lieux et des connaissances, ouvrage collectif édité par l'INCa, 2013. ,
The mammalian target of the rapamycin (mTOR) kinase pathway: its role in tumourigenesis and targeted antitumour therapy, Cell Mol Biol Lett, vol.10, issue.3, pp.479-98, 2005. ,
Combined Analysis of Efficacy: The Addition of Bevacizumab to Fluorouracil/Leucovorin Improves Survival for Patients With Metastatic Colorectal Cancer, Journal of Clinical Oncology, vol.23, issue.16, 2005. ,
DOI : 10.1200/JCO.2005.00.232
Combined Analysis of Efficacy: The Addition of Bevacizumab to Fluorouracil/Leucovorin Improves Survival for Patients With Metastatic Colorectal Cancer, Journal of Clinical Oncology, vol.23, issue.16, 2005. ,
DOI : 10.1200/JCO.2005.00.232
Angiogenesis: Basement membranes: structure, assembly and role in tumour angiogenesis, Nature Reviews Cancer, vol.3, issue.6, pp.422-455, 2003. ,
DOI : 10.1038/nrc1094
Risk of liver toxicity with the angiogenesis inhibitor pazopanib in cancer patients, Acta Oncologica, vol.28, issue.15, pp.1202-1214, 2013. ,
DOI : 10.1200/JCO.2011.41.0332
Sorafenib, Drugs, vol.359, issue.23, pp.223-263, 2009. ,
DOI : 10.1016/S0076-6879(05)07047-3
Pazopanib, Drugs, vol.71, issue.4, pp.443-54, 2011. ,
DOI : 10.2165/11588960-000000000-00000
Blocage continu de l'angiogenèse dans le cancer colorectal métastatique : bénéfices et nouvelles stratégies thérapeutiques, J Pharm Clin, vol.31, issue.4, pp.213-236, 2012. ,
Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo, Nature, vol.362, issue.6423, pp.841-844, 1993. ,
DOI : 10.1038/362841a0
Ranibizumab versus Bevacizumab for Neovascular Age-related Macular Degeneration: Results from the GEFAL Noninferiority Randomized Trial, Ophthalmology, pp.2300-2309, 2013. ,
FDA Approval Summary: Temsirolimus as Treatment for Advanced Renal Cell Carcinoma, The Oncologist, vol.15, issue.4, pp.428-463, 2010. ,
DOI : 10.1634/theoncologist.2009-0178
URL : http://theoncologist.alphamedpress.org/content/15/4/428.full.pdf
Activation de HIF1 dans le cancer : implications et conséquences, Bull Cancer, vol.93, issue.4, 2006. ,
A mathematical model for the roles of pericytes and macrophages in the initiation of angiogenesis. I. The role of protease inhibitors in preventing angiogenesis, Mathematical Biosciences, vol.168, issue.1, pp.77-115, 2000. ,
DOI : 10.1016/S0025-5564(00)00034-1
Strahlentherapie in Kombination mit platinbasierter Chemotherapie oder Cetuximab zur Behandlung von lokal fortgeschrittenen Plattenepithelkarzinomen im Kopf-Hals-Bereich, Strahlentherapie und Onkologie, vol.30, issue.17, 2014. ,
DOI : 10.1200/JCO.2011.38.4099
KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer, Cancer Res, vol.3992, p.66, 2006. ,
Induction of vascular endothelial growth factor gene expression by interleukin-1 beta in rat aortic smooth muscle cells, J Biol Chem, 1995. ,
Angiogenesis in wound repair: Angiogenic growth factors and the extracellular matrix, Microscopy Research and Technique, vol.60, issue.1, pp.107-121, 2003. ,
DOI : 10.1002/jemt.10249
Addition of thalidomide to melphalan and prednisone treatment prolongs survival in multiple myeloma - a retrospective population based study of 1162 patients, European Journal of Haematology, vol.86, issue.1, pp.19-25 ,
DOI : 10.1111/j.1600-0609.2010.01524.x
Gefitinib or Chemotherapy for Non???Small-Cell Lung Cancer with Mutated EGFR, New England Journal of Medicine, vol.362, issue.25, pp.2380-2388, 2010. ,
DOI : 10.1056/NEJMoa0909530
The growth and potential of human antiviral monoclonal antibody therapeutics, Nature Biotechnology, vol.49, issue.12, pp.1421-1455, 2007. ,
DOI : 10.1111/j.1348-0421.2005.tb03735.x
Macrophages and angiogenesis in rheumatic diseases. Vasc Cell, p.11, 2013. ,
Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration, Ophthalmology, vol.119, issue.7, 2011. ,
DOI : 10.1016/j.ophtha.2012.03.053
VEGF receptor-2 Y951 signaling and a role for the adapter molecule TSAd in tumor angiogenesis, The EMBO Journal, vol.277, issue.13, pp.2342-2353, 2005. ,
DOI : 10.4049/jimmunol.165.6.2927
Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the, 2001. ,
DOI : 10.1093/emboj/20.17.4762
URL : http://emboj.embopress.org/content/embojnl/20/17/4762.full.pdf
Ranibizumab in the ARMD wet form of agerelated macular degeneration treatment -two years results obtained from the AMADEuS Registry, Cesk Slov Oftalmol, vol.68, issue.5, pp.171-178, 2012. ,
Activation of p38 Has Opposing Effects on the Proliferation and Migration of Endothelial Cells, Journal of Biological Chemistry, vol.63, issue.22 ,
DOI : 10.1172/JCI3326
Systemic Bevacizumab (Avastin) Therapy for Neovascular Age-Related Macular DegenerationTwelve-Week Results of an Uncontrolled Open-Label Clinical Study, Ophthalmology, vol.112, issue.6, pp.1035-1082, 2005. ,
DOI : 10.1016/j.ophtha.2005.02.007
Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer, New England Journal of Medicine, vol.357, issue.26, 2007. ,
DOI : 10.1056/NEJMoa072113
Deforolimus (AP23573) a novel mTOR inhibitor in clinical development, Expert Opinion on Investigational Drugs, vol.23, issue.12, pp.1947-54, 2008. ,
DOI : 10.1016/j.ejca.2006.03.015
Gefitinib or Carboplatin???Paclitaxel in Pulmonary Adenocarcinoma, New England Journal of Medicine, vol.361, issue.10, pp.947-57, 2009. ,
DOI : 10.1056/NEJMoa0810699
A cost-benefit analysis of bevacizumab in combination with paclitaxel in the first-line treatment of patients with metastatic breast cancer, Breast Cancer Research and Treatment, vol.45, issue.8, pp.747-51 ,
DOI : 10.1016/j.ejca.2008.12.016
Paracrine induction of angiogenesis in vitro by Swiss 3T3 fibroblasts, Journal of Cell Science, vol.105, pp.1013-1024, 1992. ,
Role of thalidomide in the treatment of patients with multiple myeloma, Critical Reviews in Oncology/Hematology, vol.88, issue.1, pp.14-22, 2013. ,
DOI : 10.1016/j.critrevonc.2013.05.012
Phase 3 trial of everolimus for metastatic renal cell carcinoma, Cancer, vol.356, issue.suppl, 2010. ,
DOI : 10.1002/cncr.25219
Vascular endothelial growth factor: Crystal structure and functional mapping of the kinase domain receptor binding site, Proc. Natl Acad ,
DOI : 10.1073/pnas.93.12.5688
VEGF and the Fab fragment of a humanized neutralizing antibody: crystal structure of the complex at 2.4 ?? resolution and mutational analysis of the interface, Structure, vol.6, issue.9, pp.1153-67, 1998. ,
DOI : 10.1016/S0969-2126(98)00116-6
unitinib-induced reversible purpuric rash in a patient with gastrointestinal stromal tumor Vascular permeability factor/vascular endothelial growth factor induces lymphangiogenesis as well as angiogenesis, J Oncol Pharm ract J. Exp, 2002. ,
Recent developments in the regulation of the angiogenic switch by cellular stress factors in tumors, Cancer Letters, vol.218, issue.1, pp.1-14, 2005. ,
DOI : 10.1016/j.canlet.2004.08.007
VEGF receptor signalling in control of vascular function Angiotensin II-stimulated vascular endothelial growth factor expression in bovine retinal pericytes, Nature review Invest Ophthalmol Vis Sci, vol.7, issue.41, pp.1192-1199, 2000. ,
Continuous Lenalidomide Treatment for Newly Diagnosed Multiple Myeloma, New England Journal of Medicine, vol.366, issue.19, pp.1759-69, 2012. ,
DOI : 10.1056/NEJMoa1112704
URL : https://iris.unito.it/bitstream/2318/120025/1/nejmoa1112704.pdf
Everolimus: side effect profile and management of toxicities in breast cancer, Breast Cancer Research and Treatment, vol.47, issue.9, 2013. ,
DOI : 10.1016/j.ejca.2011.02.014
Phase II Trial of Erlotinib Plus Gemcitabine Chemotherapy in Korean Patients with Advanced Pancreatic Cancer and Prognostic Factors for Chemotherapeutic Response, Gut and Liver, vol.7, issue.5, pp.611-616, 2013. ,
DOI : 10.5009/gnl.2013.7.5.611
A Phase 3 Trial of Bevacizumab in Ovarian Cancer, ICON7 Investigators, pp.2484-96, 2011. ,
DOI : 10.1056/NEJMoa1103799
Hypoxia-induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases Emerging roles for antiangiogenesis factors in management of ocular disease, Laboratory Investigation; a Journal of Technical Methods and Pathology Clin Ophthalmol, vol.726, issue.130, pp.638-645533, 1995. ,
Role of Endothelin-1 in Neovascularization of Ovarian Carcinoma, The American Journal of Pathology, vol.157, issue.5, pp.1537-1547, 2000. ,
DOI : 10.1016/S0002-9440(10)64791-8
Retrospective Evaluation of the Clinical and Radiographic Risk Factors Associated With Severe Pulmonary Hemorrhage in First-Line Advanced, Unresectable Non???Small-Cell Lung Cancer Treated With Carboplatin and Paclitaxel Plus Bevacizumab, Journal of Clinical Oncology, vol.27, issue.9, pp.1405-1417, 2009. ,
DOI : 10.1200/JCO.2008.16.2412
overexpression induces blood vessel enlargement, tortuosity, and leakiness but no sprouting angiogenesis in the skin or mucous membranes ,
Rictor, a Novel Binding Partner of mTOR, Defines a Rapamycin-Insensitive and Raptor-Independent Pathway that Regulates the Cytoskeleton, Current Biology, vol.14, issue.14, pp.1296-1302 ,
DOI : 10.1016/j.cub.2004.06.054
Phosphorylation and regulation of, 0135. ,
PKB by the rictor-mTOR complex, Science, vol.307, pp.1098-101, 2005. ,
nomenclature internationale des différents types d'anticorps monoclonaux, Rev Med Liège, vol.64, pp.5-6, 2009. ,
Three-Year Outcomes of Individualized Ranibizumab Treatment in Patients with Diabetic Macular Edema, Ophthalmology, vol.121, issue.5, pp.491-503, 2013. ,
DOI : 10.1016/j.ophtha.2013.11.041
Epidermal growth factor receptor mutations in lung cancer, Nature Reviews Cancer, vol.64, issue.3, pp.169-81, 2007. ,
DOI : 10.1016/S1525-7304(11)70394-1
Erlotinib in Previously Treated Non???Small-Cell Lung Cancer, New England Journal of Medicine, vol.353, issue.2, pp.123-155, 2005. ,
DOI : 10.1056/NEJMoa050753
Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: implications for tumor angiogenesis., Proceedings of the National Academy of Sciences, vol.92, issue.3, pp.92-768, 1995. ,
DOI : 10.1073/pnas.92.3.768
Severe hypersensitivity pneumonitis associated with everolimus therapy for neuroendocrine tumour: a case report, BMC Research Notes, vol.6, issue.1, p.471, 2013. ,
DOI : 10.1016/j.healun.2008.03.016
Common toxicities of mammalian target of rapamycin inhibitors, Targeted Oncology, vol.118, issue.46, pp.125-134, 2011. ,
DOI : 10.1016/j.amjmed.2005.02.014
mTOR attenuates the inflammatory response in cardiomyocytes and prevents cardiac dysfunction in pathological hypertrophy, American Journal of Physiology-Cell Physiology, vol.269, issue.6, pp.1256-66, 2010. ,
DOI : 10.1161/01.RES.0000264081.78659.45
Basic Fibroblast Growth Factor Upregulates the Expression of Vascular Endothelial Growth Factor in Vascular Smooth Muscle Cells : Synergistic Interaction With Hypoxia, Circulation, vol.92, issue.1, pp.11-14, 1995. ,
DOI : 10.1161/01.CIR.92.1.11
Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial, Journal of Clinical Oncology, vol.28, issue.6 ,
DOI : 10.1200/JCO.2009.23.9764
Aflibercept versus placebo in combination with fluorouracil, leucovorin and irinotecan in the treatment of previously treated metastatic colorectal cancer: Prespecified subgroup analyses from the VELOUR trial, European Journal of Cancer, vol.50, issue.2, pp.959-804900853, 2013. ,
DOI : 10.1016/j.ejca.2013.09.013
A single autophosphorylation site on KDR/Flk-1 is essential for VEGF-A-dependent activation of PLC-gamma and DNA synthesis in vascular endothelial cells, The EMBO Journal, vol.20, issue.11, pp.2768-78, 2001. ,
DOI : 10.1093/emboj/20.11.2768
Risk of hypertension with regorafenib in cancer patients: a systematic review and meta-analysis, European Journal of Clinical Pharmacology, vol.20, issue.5, 2013. ,
DOI : 10.1093/annonc/mdn713
Intermittent chemotherapy plus either intermittent or continuous cetuximab for first-line treatment of patients with KRAS wild-type advanced colorectal cancer (COIN-B): a randomised phase 2 trial, The Lancet Oncology, vol.15, issue.6, pp.1470-204570106, 2014. ,
DOI : 10.1016/S1470-2045(14)70106-8
-regulated gene expression, The FASEB Journal, vol.16, issue.10, pp.1151-1162, 2002. ,
DOI : 10.1073/pnas.95.17.10188
Twelve-month safety of intravitreal injections of bevacizumab (Avastin??): results of the Pan-American Collaborative Retina Study Group (PACORES), Graefe's Archive for Clinical and Experimental Ophthalmology, vol.90, issue.3, pp.81-88, 2008. ,
DOI : 10.1007/s00417-007-0660-z
Xue Za Zhi. mTOR/p70s6k signaling pathway is involved in megakaryocyte polyploidization, pp.21-25, 2012. ,
IQGAP1, a Novel Vascular Endothelial Growth Factor Receptor Binding Protein, Is Involved in Reactive Oxygen Species--Dependent Endothelial Migration and Proliferation, Circulation Research, vol.95, issue.3, pp.276-283, 2004. ,
DOI : 10.1161/01.RES.0000136522.58649.60
Everolimus for Advanced Pancreatic Neuroendocrine Tumors, New England Journal of Medicine, vol.364, issue.6, pp.514-537, 2011. ,
DOI : 10.1056/NEJMoa1009290
Coût des thérapies ciblées dans le cancer colorectal métastatique, J Pharm Clin, vol.31, issue.1, pp.5-9, 2012. ,
Evaluation of efficacy and safety of sunitinib regimen in 22 patients with metastatic renal cell carcinoma: at least 12-month followup, Chin Med J (Engl), vol.126, issue.15, pp.2826-2835, 2013. ,